In our monthly nutra regulatory round-up, we look at the latest regulatory announcements happening across APAC, including China’s food industry association planning to set industry standards for electrolyte drinks, Taiwan’s harsher penalties for firms...
Australian regulators have warned of the risks of purchasing supplements from overseas in its latest safety advisory for products containing Ashwagandha (Withania somnifera).
In our monthly nutra regulatory round-up, we take a closer look at India’s stance on sugar, sweeteners and weight loss, South Korea’s support for slow-release supplements, and Taiwan FDA’s plans in limiting ashwagandha consumption amounts.
Taiwan’s Food and Drug Administration will be setting consumption limits and usage warnings on ashwagandha and seven other botanicals that are used as food ingredients.
Our first Mind and Mood Interactive Broadcast has heard that regulators are failing to match consumer demand for natural products to aid mental well-being spanning cognition, sleep, stress and anxiety in the wake of the COVID-19 pandemic.
The supplementation of ashwagandha (Withania somnifera) root and leaf extract has shown to stimulate the immune system, said a 60-day RCT conducted in India.
India’s Ministry of AYUSH has released a statement that advised against the use of ashwagandha leaves in Ayurveda and products for therapeutic purposes.
Sales of stress management supplements, which includes mood support and sleep products, have increased over 35% year-on-year, according to data provided by SPINS.
India’s BodyFirst Wellness Nutrition has partnered Bollywood star Suniel Shetty in addressing misconception around nutraceutical use and building consumer trust in the country.
A new BAPP bulletin disseminates ways to detect the adulteration of ashwagandha products with undeclared material taken from the leaves or the stems of the plant.
